7 spine device company powerhouses: What are they up to in 2018?

Written by Megan Wood | May 15, 2018 | Print  | Email

The global spinal surgery devices market will reach $13 billion by 2022, according to a Wise Guy Reports analysis.

Here are statistics and facts about seven device companies dominating the spine space. Companies are listed in alphabetical order.

DePuy Synthes (Raynham, Mass.)
A part of New Brunswick, N.J.-based Johnson & Johnson, DePuy Synthes saw a 1.1 percent sales growth in the first quarter of 2018, compared to the first quarter of 2017. The company's spine business sales experienced the greatest decline, at 8.9 percent, reaching $804 million. J&J's orthopedic segment dropped to $9.25 billion in 2017 full-year sales, compared to $9.33 billion in 2016.

Here's what the company has been up to in 2018:

Globus Medical (Audubon, Pa.)
For the first quarter of 2018, Globus Medical reported an 11.9 percent increase in global sales to $174.4 million. The company reported $12.8 million in revenue from emerging technologies, partially due to demand for the Company's ExcelsiusGPS robotics navigation system. U.S. spine business grew 4 percent in the first quarter over the first quarter of 2017 on a day-adjusted basis. Globus plans to invest in imaging, navigations, robotics and trauma in the future. The company saw global sales of $636 million in 2017.

Here's what the company has been up to in 2018:

K2M (Leesburg, Va.)
K2M's 2018 first quarter revenues increased 10 percent year-over-year, hitting $67.88 million. The U.S. complex spine business saw an 8 percent growth year-over-year. In the first quarter of 2018, the segment brought in $18.51 million in revenue. The company's minimally invasive segment grew to $8.38 million in the first quarter of 2018. K2M reported 2017 revenue of $258 million.

Here's what the company has been up to in 2018:

Medtronic (Dublin, Ireland)
Medtronic reported third quarter 2018 revenue of $7.3 billion. The company's spine revenue reached $661 million, increasing 1 percent. Medtronic reported $7.4 billion in sales for fiscal year 2017.

Here's what the company has been up to in 2018:

NuVasive (San Diego)
NuVasive saw 2018 first quarter revenues increase 4.6 percent year-over-year to $260.5 million. However, the company reported a $27.1 million net loss for the quarter, mostly due to litigation liability totaling $29 million related to an ongoing lawsuit. The company's full-year 2017 revenue hit $1.03 billion.

Here's what the company has been up to in 2018:

Stryker (Kalamazoo, Mich.)
Stryker reported net sales increased 9.7 percent year-over-year, generating $3.2 billion. The company's orthopedic segment jumped 7.1 percent in sales year-over-year. Stryker's neurotechnology and spine segment experienced the largest growth; net sales totaled $600 million for the quarter. Stryker's 2017 full-year net sales increased 9.9 percent to $12.4 billion. Neurotechnology and spine sales grew 8.2 percent to $2.1 billion.

Here's what the company has been up to in 2018:

Zimmer Biomet (Warsaw, Ind.)
Zimmer Biomet saw $2 billion-plus in net sales in the first quarter of 2018. The company's spine segment sales reached about $183 million for the quarter, a decrease of 1.7 percent year-over-year. The company reported $7.82 billion in full-year 2017 sales.

Here's what the company has been up to in 2018:

More articles on devices:
DePuy Synthes signs agreement to acquire impactor developer: 5 insights
OrthoPediatrics receives FDA clearance for 25th surgical system: 3 insights
3M warming system in hot water over allegedly causing joint infections: 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.